Aldeyra Therapeutics (ALDX) Earnings Date, Estimates & Call Transcripts

$5.55

-0.01 (-0.18%)

(As of 10/17/2024 ET)

ALDX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ALDX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Porter & Company

War on Elon Escalates…

A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.

One company holds a near-total monopoly on it.

Aldeyra Therapeutics Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	2	($0.15)	$0.02	($0.07)
Q2 2024	2	($0.15)	($0.14)	($0.15)
Q3 2024	2	($0.19)	($0.17)	($0.18)
Q4 2024	2	($0.18)	$1.38	$0.60
FY 2024	8	($0.67)	$1.09	$0.21

ALDX Earnings Date and Information

Aldeyra Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 1st, 2024 based off prior year's report dates.

Aldeyra Therapeutics Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
11/1/2024 (Estimated)	-	-	-	-	-	-	-
5/2/2024	Q1 2024	($0.08)	($0.14)	($0.06)	($0.14)	-	-
3/7/2024	Q4 2023	($0.21)	($0.08)	+$0.13	($0.08)	-	-
11/3/2023	Q3 2023	-	($0.14)	($0.14)	($0.14)	-	-
8/3/2023	Q2 2023	($0.31)	($0.15)	+$0.16	($0.15)	-	-
5/4/2023	Q1 2023	($0.30)	($0.27)	+$0.03	($0.27)	-	-
3/9/2023	Q4 2022	($0.34)	($0.22)	+$0.12	($0.22)	-	-
Get the Latest News and Ratings for ALDX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Aldeyra Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
11/10/2022	Q3 2022	($0.34)	($0.25)	+$0.09	($0.25)	-	-
8/5/2022	Q2 2022	($0.32)	($0.30)	+$0.02	($0.30)	-	-
5/5/2022	Q1 2022	($0.31)	($0.29)	+$0.02	($0.29)	-	-
3/17/2022	Q4 2021	($0.31)	($0.27)	+$0.04	($0.27)	-	-
10/27/2021	Q3 2021	($0.26)	($0.27)	($0.01)	($0.27)	-	-
8/4/2021	Q2 2021	($0.24)	($0.28)	($0.04)	($0.28)	-	-
5/5/2021	Q1 2021	($0.29)	($0.25)	+$0.04	($0.25)	-	-
3/10/2021	Q4	($0.28)	($0.30)	($0.02)	($0.35)	-	-
11/10/2020	Q3 2020	($0.27)	($0.23)	+$0.04	($0.23)	-	-
8/6/2020	Q2 2020	($0.34)	($0.25)	+$0.09	($0.25)	-	-
5/7/2020	Q1 2020	($0.48)	($0.34)	+$0.14	($0.34)	-	-
3/12/2020	Q4 2019	($0.68)	($0.47)	+$0.21	($0.47)	-	-
11/7/2019	Q3	($0.55)	($0.69)	($0.14)	($0.69)	-	-

Aldeyra Therapeutics Earnings - Frequently Asked Questions

When is Aldeyra Therapeutics's earnings date?: Aldeyra Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 1st, 2024 based off last year's report dates. Learn more on ALDX's earnings history.
How much profit does Aldeyra Therapeutics generate each year?: Aldeyra Therapeutics (NASDAQ:ALDX) has a recorded net income of -$37.54 million. ALDX has generated -$0.51 earnings per share over the last four quarters.
What is Aldeyra Therapeutics's EPS forecast for next year?: Aldeyra Therapeutics's earnings are expected to decrease from ($0.51) per share to ($0.56) per share in the next year.